<?xml version="1.0" encoding="UTF-8"?>
<p class="p">For the main component silybin, a large amount of pharmaco-toxicological and clinical documentation exists [
 <xref rid="B24-molecules-24-02155" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B25-molecules-24-02155" ref-type="bibr" class="xref">25</xref>,
 <xref rid="B26-molecules-24-02155" ref-type="bibr" class="xref">26</xref>]. The molecular structure representative of one of the two diastereoisomers (silybin A and silybin B, 1: 1 mixture) is shown in 
 <xref ref-type="fig" rid="molecules-24-02155-f001" class="xref">Figure 1</xref>.
</p>
